Fujifilm Holdings Corp. said Monday it is preparing to manufacture up to 300,000 new courses of treatment of its anti-influenza drug for use in people with Ebola virus disease—the latest sign of the drug industry’s scramble to help contain the widening outbreak.
from WSJ.com: US Business http://ift.tt/10dXsDl
via IFTTT
from WSJ.com: US Business http://ift.tt/10dXsDl
via IFTTT
No comments:
Post a Comment